Toronto Dominion Bank’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.32M Sell
21,221
-2,816
-12% -$701K 0.01% 831
2025
Q4
$6.61M Sell
24,037
-6,594
-22% -$1.8M 0.01% 763
2025
Q3
$8.04M Sell
30,631
-483
-2% -$117K 0.01% 684
2025
Q2
$6.81M Buy
31,114
+725
+2% +$155K 0.01% 681
2025
Q1
$6.8M Sell
30,389
-9,429
-24% -$2.6M 0.01% 606
2024
Q4
$13M Buy
39,818
+3,573
+10% +$1.12M 0.02% 461
2024
Q3
$10.9M Buy
36,245
+334
+0.9% +$102K 0.02% 440
2024
Q2
$11.8M Sell
35,911
-6,364
-15% -$2.25M 0.02% 442
2024
Q1
$16.7M Buy
42,275
+862
+2% +$319K 0.03% 368
2023
Q4
$14.6M Buy
41,413
+3,454
+9% +$1.22M 0.02% 458
2023
Q3
$14.2M Sell
37,959
-1,510
-4% -$584K 0.02% 419
2023
Q2
$15.1M Buy
39,469
+1,611
+4% +$576K 0.02% 431
2023
Q1
$13.1M Buy
37,858
+28
+0.1% +$8.18K 0.02% 431
2022
Q4
$8.9M Buy
37,830
+6,315
+20% +$1.5M 0.01% 539
2022
Q3
$7.75M Sell
31,515
-3,815
-11% -$1.16M 0.01% 553
2022
Q2
$10.7M Sell
35,330
-9,084
-20% -$2.96M 0.02% 400
2022
Q1
$18.2M Sell
44,414
-5,329
-11% -$2.09M 0.03% 314
2021
Q4
$23.3M Buy
49,743
+6,015
+14% +$2.59M 0.03% 312
2021
Q3
$18.6M Buy
43,728
+10,634
+32% +$4.48M 0.03% 314
2021
Q2
$11.9M Sell
33,094
-4,063
-11% -$1.34M 0.02% 420
2021
Q1
$10.5M Sell
37,157
-10,038
-21% -$2.87M 0.02% 423
2020
Q4
$13.4M Buy
47,195
+4,563
+11% +$1.28M 0.02% 366
2020
Q3
$11.7M Sell
42,632
-6,950
-14% -$1.84M 0.03% 348
2020
Q2
$11.3M Buy
49,582
+38,059
+330% +$7.48M 0.03% 407
2020
Q1
$1.76M Sell
11,523
-2,807
-20% -$432K 0.01% 665
2019
Q4
$2.15M Buy
14,330
+13,040
+1,011% +$1.9M ﹤0.01% 734
2019
Q3
$183K Buy
+1,290
New +$178K ﹤0.01% 1121
2019
Q2
Sell
-1,745
Closed -$192K 1777
2019
Q1
$192K Sell
1,745
-12
-0.7% -$1.25K ﹤0.01% 1176
2018
Q4
$172K Sell
1,757
-438
-20% -$47.5K ﹤0.01% 1117
2018
Q3
$271K Hold
2,195
﹤0.01% 1042
2018
Q2
$218K Buy
2,195
+272
+14% +$25K ﹤0.01% 1129
2018
Q1
$170K Buy
1,923
+1,713
+816% +$160K ﹤0.01% 1072
2017
Q4
$21K Hold
210
﹤0.01% 1143
2017
Q3
$20K Buy
+210
New +$19K ﹤0.01% 1058
2016
Q2
Sell
-27
Closed -$2K 1312
2016
Q1
$2K Buy
+27
New +$1.62K ﹤0.01% 1179

Other funds holding WST

Toronto Dominion Bank's WST Position: Q1 2026 in Review

Toronto Dominion Bank reduced its West Pharmaceutical (WST) stake by 12% in Q1 2026, selling an estimated $701K and leaving 21,221 shares worth $5.32M. The position accounts for 0.01% of the portfolio, ranked #831.

Toronto Dominion Bank first reported a position in WST in Q1 2016 and has held it in 35 quarters since. The position peaked at $23.3M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Toronto Dominion Bank held 21,221 shares of West Pharmaceutical worth $5.32M as of Q1 2026.
  • Toronto Dominion Bank sold 2,816 West Pharmaceutical shares in Q1 2026, an estimated $701K.
  • West Pharmaceutical made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #831 holding.
  • Toronto Dominion Bank first reported a position in West Pharmaceutical in Q1 2016 and has held it in 35 quarters since.
  • Toronto Dominion Bank's West Pharmaceutical position peaked at $23.3M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.